Intangible asset and assets held for sale (Details) $ in Thousands, $ in Thousands |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
|
Oct. 06, 2022
$ / Option
|
Dec. 31, 2025
patent
|
Dec. 31, 2024
USD ($)
|
Dec. 31, 2024
CAD ($)
|
Jul. 29, 2025
USD ($)
|
Jan. 01, 2024
USD ($)
|
|
| Intangible asset and assets held for sale | ||||||
| Number of patents licensed | patent | 3 | |||||
| Put option strike price | $ / Option | 3,000 | |||||
| Impairment of intangible asset | $ 2,905 | $ 3,961 | ||||
| NWMT | ||||||
| Intangible asset and assets held for sale | ||||||
| Ownership interest acquired through license exchange (as percent) | 15.00% | |||||
| NWPT | ||||||
| Intangible asset and assets held for sale | ||||||
| Call option strike price | $ / Option | 3,000 | |||||
| NWPT | NWMT | ||||||
| Intangible asset and assets held for sale | ||||||
| Ownership interest (as percent) | 85.00% | |||||
| Assets held for sale | ||||||
| Intangible asset and assets held for sale | ||||||
| Fair value | $ | $ 2,992 | |||||
| Amphotericin B Technologies, Inc disposal group, not discontinued operations | ||||||
| Intangible asset and assets held for sale | ||||||
| Consideration received | $ | $ 10 | |||||